Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Hematologic Neoplasms 272Leukemia, Myeloid, Acute 255Leukemia 234Lymphoma 127Leukemia, Lymphocytic, Chronic, B-Cell 110Multiple Myeloma 108Neoplasms 95Myelodysplastic Syndromes 95Lymphoma, Non-Hodgkin 94Hodgkin Disease 76Burkitt Lymphoma 64Lymphoma, Mantle-Cell 61Lymphoma, Follicular 60Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Lymphoma, Large B-Cell, Diffuse 56Myeloproliferative Disorders 54Lymphoma, B-Cell, Marginal Zone 53Lymphoma, Large-Cell, Immunoblastic 47Congenital Abnormalities 47Motor Activity 45Leukemia, Myeloid, Chronic-Phase 45Primary Myelofibrosis 43Lymphoma, T-Cell, Cutaneous 43Recurrence 41Sezary Syndrome 39Mycosis Fungoides 39Leukemia, Myeloid, Accelerated Phase 38Neoplasms, Plasma Cell 35Breast Neoplasms 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neurobehavioral Manifestations × Other hematologic neoplasm × Clear all
NCT02043184 2017-06-07

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Michigan State University

Phase NA Completed
322 enrolled
BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Behavioral Symptoms, Breast Neoplasms, Depression, Leukemia, Melanoma, Neoplasms, Patient Acceptance of Health Care, Prostatic Neoplasms, Colorectal Neoplasms, Neurobehavioral Manifestations, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡